A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

This CTD dossier owner and manufacturer, established in the late 1990s, has a strong presence in the global pharmaceutical market. They specialize in developing and manufacturing a wide range of prescription and over-the-counter medications, encompassing various therapeutic areas. With over 250 products currently available and 50 in development, the company boasts a diverse portfolio covering a wide range of dosage forms, including solids, liquids, and injectables. Their extensive production lines are compliant with both EU and US GMP standards, demonstrating a commitment to quality and safety. The company has a significant presence in multiple regions, including North America and Europe. Their track record demonstrates a dedication to scientific innovation and a focus on producing high-quality healthcare solutions.